Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||
| Cash income from operating activities | -34.13%199.79K | -26.33%303.29K | 83.30%411.7K | -39.74%224.61K | -27.17%372.76K | 117.03%511.85K | 101.29%235.85K | 117.17K |
| Revenue from customers | -238.24%-31.81K | -38.88%23.01K | --37.64K | ---- | ---- | ---- | ---- | ---- |
| Income from government grants | ---- | ---- | ---- | ---- | --49.9K | ---- | ---- | ---- |
| Other cash income from operating activities | -17.37%231.59K | -25.07%280.28K | 66.54%374.06K | -30.43%224.61K | -36.92%322.86K | 117.03%511.85K | 101.29%235.85K | --117.17K |
| Cash paid | -6.65%-1.27M | 17.53%-1.19M | 10.65%-1.44M | -23.32%-1.61M | 10.70%-1.31M | 32.13%-1.46M | -23.97%-2.15M | -1.74M |
| Payments to suppliers for goods and services | -6.65%-1.27M | 17.53%-1.19M | 10.65%-1.44M | -23.32%-1.61M | 10.70%-1.31M | 32.13%-1.46M | -23.97%-2.15M | ---1.74M |
| Direct interest paid | -59.82%-34.97K | -1,741.67%-21.88K | 59.84%-1.19K | 22.85%-2.96K | -8.34%-3.83K | ---3.54K | ---- | ---- |
| Direct interest received | -47.25%2.34K | -74.01%4.44K | 160.55%17.1K | 256.68%6.56K | -78.45%1.84K | -84.82%8.54K | 23.61%56.25K | --45.51K |
| Operating cash flow | -21.93%-1.1M | 10.92%-900.95K | 26.83%-1.01M | -47.81%-1.38M | 1.10%-935.19K | 49.23%-945.59K | -18.23%-1.86M | ---1.58M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | 0 | 15.97K | 98.03%-5.35K | -24,845.28%-272.15K | 97.07%-1.09K | 72.48%-37.21K | -135.2K | |
| Net PPE purchase and sale | ---- | ---- | ---- | 92.58%-5.35K | -6,513.47%-72.15K | 97.07%-1.09K | 53.60%-37.21K | ---80.2K |
| Net business purchase and sale | ---- | --15.97K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---200K | ---- | ---- | ---55K |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | --0 | --15.97K | ---- | 98.03%-5.35K | -24,845.28%-272.15K | 97.07%-1.09K | 72.48%-37.21K | ---135.2K |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 231.68%1.58M | 1,889.31%475.49K | 18.70%-26.57K | -100.97%-32.69K | 408.91%3.37M | 1,474.70%663.14K | -99.09%42.11K | 4.65M |
| Net issuance payments of debt | ---- | ---- | ---- | -528.40%-26.48K | -69.55%6.18K | --20.3K | ---- | ---5.66K |
| Net common stock issuance | 219.42%1.61M | --502.96K | ---- | -99.41%20K | 408.25%3.4M | 1,486.20%667.98K | -99.10%42.11K | --4.66M |
| Net other financing activities | 46.40%-29.44K | -3.36%-54.94K | -1.38%-53.15K | 0.80%-52.42K | -5.12%-52.85K | ---50.28K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 231.68%1.58M | 1,889.31%475.49K | 18.70%-26.57K | -100.97%-32.69K | 408.91%3.37M | 1,474.70%663.14K | -99.09%42.11K | --4.65M |
| Net cash flow | ||||||||
| Beginning cash position | -74.69%138.76K | -65.44%548.25K | -47.24%1.59M | 258.29%3.01M | -25.26%839.16K | -62.33%1.12M | 7,311.84%2.98M | --40.21K |
| Current changes in cash | 216.87%478.56K | 60.55%-409.49K | 26.92%-1.04M | -165.53%-1.42M | 864.40%2.17M | 84.74%-283.55K | -163.18%-1.86M | --2.94M |
| End cash Position | 344.90%617.32K | -74.69%138.76K | -65.44%548.25K | -47.24%1.59M | 258.29%3.01M | -25.26%839.16K | -62.33%1.12M | --2.98M |
| Free cash from | -21.93%-1.1M | 10.92%-900.95K | 27.11%-1.01M | -37.75%-1.39M | -6.41%-1.01M | 50.17%-946.69K | -14.75%-1.9M | ---1.66M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |